14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
JHX vs CRH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, James Hardie Industries plc (JHX) captures the overall head-to-head institutional edge over CRH Public Limited Company (CRH) on higher Unified Composite conviction (50.0/100 HOLD vs. 46.0/100 HOLD) after splitting the core matrix 4–6 (led by Growth & Scale, Profitability & Quality), while CRH wins 3–2 across the 6-pillar growth and valuation breakdown. JHX trades at $26.48 (21.6x Forward P/E, 16.5% operating margin) versus CRH at $88.05 (14.7x Forward P/E, 14.1% operating margin).
Growth vs. Quality Trade-Off: JHX earns the overall head-to-head edge with a stronger Unified Composite Score (50.0/100 HOLD vs. CRH 46.0/100 HOLD) and 1.61β · 50% Vol risk profile, whereas CRH leads top-line expansion (+3.0% YoY revenue growth, 1.63x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: JHX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.5); meanwhile CRH is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on JHX vs CRH. Trailing 12-month operating profitability (JHX 16.5% vs CRH 14.1%) and valuation multiples (JHX 21.6x vs CRH 14.7x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Building Materials value chain with $60.2B market capitalization and 14.1% operating margin.
OpEx & R&D Reinvestment22.1% of Rev ($8.61B)
90D Engineering Disclosures0 Published
Investor FAQ JHX vs CRH Key Questions & Quantitative Answers
As of Nov 20, 2026, James Hardie Industries plc (JHX) captures the overall head-to-head institutional edge over CRH Public Limited Company (CRH) on higher Unified Composite conviction (50.0/100 HOLD vs. 46.0/100 HOLD) after splitting the core matrix 4–6 (led by Growth & Scale, Profitability & Quality), while CRH wins 3–2 across the 6-pillar growth and valuation breakdown. JHX trades at $26.48 (21.6x Forward P/E, 16.5% operating margin) versus CRH at $88.05 (14.7x Forward P/E, 14.1% operating margin). Growth vs. Quality Trade-Off: JHX earns the overall head-to-head edge with a stronger Unified Composite Score (50.0/100 HOLD vs. CRH 46.0/100 HOLD) and 1.61β · 50% Vol risk profile, whereas CRH leads top-line expansion (+3.0% YoY revenue growth, 1.63x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: JHX is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 45.5); meanwhile CRH is in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 43.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
JHX leads the Growth & Scale pillar: JHX posts +23.7% YoY revenue growth and +23.4% YoY earnings growth on $5.66B TTM revenue (37.6% gross margin, 16.5% operating margin), compared with CRH at +3.0% YoY revenue growth and -15.8% YoY earnings growth on $39.0B TTM revenue (36.2% gross margin, 14.1% operating margin). On trailing 12-month operating scale, JHX generates $5.66B in USD-normalized revenue versus $39.0B for CRH. In operating R&D and SG&A reinvestment, JHX deploys 21.1% of Rev ($1.20B) (0 90-day corporate R&D disclosures) versus 22.1% of Rev ($8.61B) (0 disclosures) for CRH.
CRH screens cheaper on headline valuation multiples. JHX trades at 21.6x Forward P/E, 46.2x Trailing P/E, 1.24x PEG, and 2.7x EV/Revenue (27.8% EBITDA margin), whereas CRH trades at 14.7x Forward P/E, 17.1x Trailing P/E, 1.63x PEG, and 1.5x EV/Revenue (19.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against JHX (5.5% ROE) versus CRH (13.9% ROE) capital efficiency.
In options market volatility and institutional positioning, JHX carries 44.6% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.61β · 50% Vol realized risk). By comparison, CRH carries 19.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.04β · 43% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.